Yi Xue

575 total citations
37 papers, 398 citations indexed

About

Yi Xue is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Yi Xue has authored 37 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Yi Xue's work include Tuberculosis Research and Epidemiology (23 papers), Mycobacterium research and diagnosis (18 papers) and Infectious Diseases and Tuberculosis (4 papers). Yi Xue is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Mycobacterium research and diagnosis (18 papers) and Infectious Diseases and Tuberculosis (4 papers). Yi Xue collaborates with scholars based in China and United States. Yi Xue's co-authors include Yuanyuan Shang, Fengmin Huo, Robert V. Stahelin, Emmanuel Adu‐Gyamfi, Lingling Dong, Enrico Gratton, Smita P. Soni, Michelle A. Digman, Yu Pang and Hairong Huang and has published in prestigious journals such as Journal of Biological Chemistry, Water Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Yi Xue

35 papers receiving 387 citations

Peers

Yi Xue
Aram Yegiazaryan United States
Yi Xue
Citations per year, relative to Yi Xue Yi Xue (= 1×) peers Aram Yegiazaryan

Countries citing papers authored by Yi Xue

Since Specialization
Citations

This map shows the geographic impact of Yi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xue more than expected).

Fields of papers citing papers by Yi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xue. The network helps show where Yi Xue may publish in the future.

Co-authorship network of co-authors of Yi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xue. A scholar is included among the top collaborators of Yi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xue. Yi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Yi, Xuyan Li, Zhijin Zhang, et al.. (2025). Longitudinal multi-omics analysis of convalescent individuals with respiratory sequelae 6–36 months after COVID-19. BMC Medicine. 23(1). 134–134. 2 indexed citations
3.
Jiang, Guanglu, Rongmei Liu, Yi Xue, et al.. (2025). Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study. Infection and Drug Resistance. Volume 18. 261–268. 3 indexed citations
4.
Yu, Xia, Fen Wang, Lingling Dong, et al.. (2023). Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum. Microbiology Spectrum. 11(4). e0126523–e0126523. 4 indexed citations
5.
Yu, Xia, Yuanyuan Shang, Yi Xue, et al.. (2023). In vitro and Intracellular Antibacterial Activity of Sudapyridine (WX-081) Against Tuberculosis. Infection and Drug Resistance. Volume 16. 217–224. 9 indexed citations
6.
Wang, Kejie, et al.. (2023). Analysis of the regulatory role of miR-34a-5p/PLCD3 in the progression of osteoarthritis. Functional & Integrative Genomics. 23(2). 131–131. 1 indexed citations
7.
Chen, Suting, Congli Wang, Zhaojing Zong, et al.. (2023). Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis. Clinica Chimica Acta. 553. 117697–117697. 5 indexed citations
8.
Chen, Suting, Fen Wang, Yi Xue, et al.. (2022). Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm. Infection and Drug Resistance. Volume 15. 3347–3355. 8 indexed citations
9.
An, Jun, Wei Shu, Kai Tang, et al.. (2022). Impact of Xpert MTB/RIF on Outcomes of Adults Hospitalized With Spinal Tuberculosis: Findings From a Comparative Cohort in Beijing, China. Frontiers in Public Health. 10. 901504–901504. 3 indexed citations
10.
Yu, Xia, et al.. (2022). In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus. Frontiers in Microbiology. 13. 926361–926361. 4 indexed citations
11.
Wang, Guirong, Fengmin Huo, Yi Xue, et al.. (2022). Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China. Frontiers in Medicine. 9. 1067516–1067516. 16 indexed citations
12.
Yu, Xia, Fengmin Huo, Fen Wang, et al.. (2021). In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China. Infection and Drug Resistance. Volume 14. 4689–4697. 12 indexed citations
13.
Jing, Wei, Zhaojing Zong, Bo‐Hao Tang, et al.. (2020). Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China. Antimicrobial Agents and Chemotherapy. 64(3). 25 indexed citations
14.
Zhang, Fuzhen, Shanshan Li, Shu’an Wen, et al.. (2020). <p>Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from <em>Mycobacterium tuberculosis</em></p>. Infection and Drug Resistance. Volume 13. 815–822. 18 indexed citations
15.
Liang, Qian, Yuanyuan Shang, Fengmin Huo, et al.. (2020). Assessment of current diagnostic algorithm for detection of mixed infection with Mycobacterium tuberculosis and nontuberculous mycobacteria. Journal of Infection and Public Health. 13(12). 1967–1971. 11 indexed citations
16.
Wang, Jun, Rongmei Liu, Fengmin Huo, et al.. (2020). <p>Rapid Detection of Ethambutol-Resistant <em>Mycobacterium tuberculosis</em> from Sputum by High-Resolution Melting Analysis in Beijing, China</p>. Infection and Drug Resistance. Volume 13. 3707–3713. 6 indexed citations
17.
Huo, Fengmin, Yifeng Ma, Shanshan Li, et al.. (2020). Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China. Journal of Molecular Diagnostics. 22(9). 1199–1204. 14 indexed citations
18.
Wen, Shu’an, Tingting Zhang, Xia Yu, et al.. (2020). Bone penetration of linezolid in osteoarticular tuberculosis patients of China. International Journal of Infectious Diseases. 103. 364–369. 5 indexed citations
19.
Wen, Shu’an, Wei Jing, Tingting Zhang, et al.. (2019). Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 38(7). 1293–1296. 39 indexed citations
20.
Adu‐Gyamfi, Emmanuel, Smita P. Soni, Yi Xue, et al.. (2013). The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane. Journal of Biological Chemistry. 288(8). 5779–5789. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026